Citing 'safety' and 'freedom,' HHS will allow compounding of certain wellness peptides
HHS on Wednesday said it will stop enforcing a ban on the compounding of certain popular peptides used for wellness purposes while the FDA works …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Pfizer India site closure risks exacerbating cancer drug shortages October 28, 2026
Treasury's COINS rule draft would narrow the path for China biotech dealmaking, experts say October 27, 2026
Lilly's ads can continue after Novo challenge, judge rules October 27, 2026
Anthropic's latest biotech buy is a one-man stealth startup run by a pseudonymous Twitter poster
Backed by Amish and Mennonites, a new kind of gene therapy company takes shape
Now 78% of scientists say AI will speed drug discovery this year: Signal Survey
Source link







